HPVHPV type prevalencevaccinevaccine effectivenessBackground. Effectiveness of human papillomavirus (HPV) vaccines in the context of both guidelines, which recommend vaccination at 14 years and modest vaccine coverage, is poorly documented.Heard, IsabelleTondeur, LauraArowas, LaurenceDemazoin, MarieFalgui...
Human papillomavirus (HPV) infection has been shown to be a major risk factor for cervical cancer. Vaccines against HPV-16 and HPV-18 are highly effective in preventing type-specific HPV infections and related cervical lesions. There is, however, limited
The analysis on cross-protective activity exercised by bivalent and quadrivalent vaccines shows that the bivalent vaccine could prevent more pre-cancerous lesions and cases of cervicocarcinoma than quadrivalent, and that the latter could prevent genital warts that are not prevented by bivalent. The ...
Human papillomavirus (HPV) infection has been shown to be a major risk factor for cervical cancer. Vaccines against HPV-16 and HPV-18 are highly effective in preventing type-specific HPV infections and related cervical lesions. There is, however, limited
Abstract Prophylactic human papillomavirus (HPV) vaccines are administered in vaccination programs, targeted at young adolescent girls before sexual exposu... D Vincenzo,R.,Ricci,... - 《Gynecologic Oncology》 被引量: 44发表: 2013年 Changes in the prevalence of human papillomavirus following a natio...
Population-Level Impact of the Bivalent, Quadrivalent, and Nonavalent Human Papillomavirus Vaccines: A Model–Based Analysis Bivalent and quadrivalent human papillomavirus (HPV) vaccines are now licensed in several countries. Furthermore, clinical trials examining the efficacy of... Nicolas,Van,de,......
Assessing cost-effectiveness of HPV vaccines with decision analytic models: what are the distinct challenges of low- and middle-income countries? A protocol for a systematic review Article Open access 12 May 2015 Background Although not specifically mentioned in the millennium development goals (MDG...
Pay-it-forward is hypothesized to be more effective than standard-of-care in increasing HPV vaccination among 15–18-year-old adolescent girls. Study findings will have implications for filling the gaps in HPV vaccine service delivery in places where HPV vaccines are provided for a fee and may...
- 《Journal of Infectious Diseases》 被引量: 870发表: 2013年 Evaluating Human Papillomavirus Vaccination Programs Human papillomavirus (HPV) has been implicated as the primary etiologic agent of cervical cancer. Potential vaccines against high-risk HPV types are in cli... AV Taira,CP Neukermans,...
AimClinical trials have shown prophylactic human papillomavirus (HPV) vaccines to be effective against infection and disease. We examined whether HPV vacci... M Brisson,NVD Velde,PD Wals,... - 《Vaccine》 被引量: 355发表: 2007年 Cost-effectiveness of human papillomavirus vaccination and screening...